From implantable devices like pacemakers and brain interfaces to smart wearables, humans are fast becoming more cybernetic than we might realize. Implanted devices tend to have higher fidelity and ...

Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and ...

Conduit Pharmaceuticals has partnered with SARBORG Limited to utilize an advanced artificial intelligence and cybernetics platform aimed at improving various drug development processes, such as drug ...

Collaboration reinforces Conduit’s commitment to leveraging AI and cybernetics to reduce human error, lower costs, and accelerate timelines in drug development Sarborg delivers a prototype AI-product ...

Conduit Pharmaceuticals (CDT) announced that it has entered into an agreement with SARBOR to leverage an advanced artificial intelligence and cybernetics platform to evaluate key deliverables across ...

As the body’s most external organ, skin is privileged for human-computer interfaces because it can be accessed non-invasively. Despite much progress on thin flexible devices that conform to skin for ...